Apoptosis and chemoresistance in human ovarian cancer: Is Xiap a determinant?

被引:0
|
作者
Li, JL
Sasaki, H
Sheng, YL
Schneiderman, D
Xiao, CW
Kotsuji, F
Tsang, BK
机构
[1] Univ Ottawa, Loeb Hlth Res Inst, Ottawa Hosp, Dept Obstet & Gynaecol,Div Gynaecol Oncol, Ottawa, ON K1Y 4E9, Canada
[2] Univ Ottawa, Loeb Hlth Res Inst, Ottawa Hosp, Reprod Biol Unit, Ottawa, ON K1Y 4E9, Canada
[3] Univ Ottawa, Loeb Hlth Res Inst, Ottawa Hosp, Dept Cellular & Mol Med, Ottawa, ON K1Y 4E9, Canada
[4] Fukui Med Univ, Dept Obstet & Gynaecol, Fukui, Japan
来源
BIOLOGICAL SIGNALS AND RECEPTORS | 2000年 / 9卷 / 02期
关键词
apoptosis; inhibitor of apoptosis proteins; Fas/Fas ligand; caspases; p53; MDM2; focal adhesion kinase; chemoresistance; human ovarian cancer; gene therapy;
D O I
暂无
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Cisplatin-induced apoptosis in epithelial ovarian cancer cells is in part a consequence of suppressed Xiap expression and upregulation of the Fas/FasL system. Changes in the expression of these 'cell death' and 'cell survival' genes lead to activation of caspase-3, and cleavage of MDM2 and FAK, Failure of cancer cells to maintain a balance in the expression of these genes in favor of apoptotic cell death may be an important factor of chemoresistance. Xiap may be a novel target for gene therapy of human ovarian epithelial cancer a nd, dependent on P53 status, expression of Xiap antisense alone or in combination with wild-type P53 sense may offer a new approach for the treatment of the chemoresistant cancer. Copyright (C) 2000 S. Karger AG, Basel.
引用
收藏
页码:122 / 130
页数:9
相关论文
共 50 条
  • [21] Adipocytes promote ovarian cancer chemoresistance
    Yang, Jiang
    Zaman, Munir M.
    Vlasakov, Iliyan
    Roy, Roopali
    Huang, Lan
    Martin, Camilia R.
    Freedman, Steven D.
    Serhan, Charles N.
    Moses, Marsha A.
    SCIENTIFIC REPORTS, 2019, 9 (1)
  • [22] Tumor evolution and chemoresistance in ovarian cancer
    Kim, Soochi
    Han, Youngjin
    Kim, Se Ik
    Kim, Hee-Seung
    Kim, Seong Jin
    Song, Yong Sang
    NPJ PRECISION ONCOLOGY, 2018, 2
  • [23] Adipocytes promote ovarian cancer chemoresistance
    Jiang Yang
    Munir M. Zaman
    Iliyan Vlasakov
    Roopali Roy
    Lan Huang
    Camilia R. Martin
    Steven D. Freedman
    Charles N. Serhan
    Marsha A. Moses
    Scientific Reports, 9
  • [24] CHEMORESISTANCE IN COLONIC AND OVARIAN-CANCER
    FIORENTINO, M
    TOSO, S
    RESISTANCE TO ANTITUMOR AGENTS: LABORATORY AND CLINICAL STUDIES, 1989, 7 : 202 - 211
  • [25] Tumor evolution and chemoresistance in ovarian cancer
    Soochi Kim
    Youngjin Han
    Se Ik Kim
    Hee-Seung Kim
    Seong Jin Kim
    Yong Sang Song
    npj Precision Oncology, 2
  • [26] Regulation of HtrA2/Omi by X-linked inhibitor of apoptosis protein in chemoresistance in human ovarian cancer cells
    Yang, XK
    Xing, H
    Gao, QL
    Chen, G
    Lu, YP
    Wang, SX
    Ma, D
    GYNECOLOGIC ONCOLOGY, 2005, 97 (02) : 413 - 421
  • [27] X-linked inhibitor of apoptosis protein in human ovarian cancer: Possible role in chemoresistance and target for gene therapy.
    Tsang, BK
    BIOLOGY OF REPRODUCTION, 2000, 62 : 98 - 98
  • [28] XIAP as a target for therapeutic apoptosis in prostate cancer
    Devi, GR
    DRUG NEWS & PERSPECTIVES, 2004, 17 (02) : 127 - 134
  • [29] Apoptosis and chemoresistance in transgenic cancer models
    Schmitt, CA
    Lowe, SW
    JOURNAL OF MOLECULAR MEDICINE-JMM, 2002, 80 (03): : 137 - 146
  • [30] Apoptosis and chemoresistance in transgenic cancer models
    Clemens A. Schmitt
    Scott W. Lowe
    Journal of Molecular Medicine, 2002, 80 : 137 - 146